http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
화상 중환자실과 비화상 중환자실 폐 침윤 환자에서 기관지폐포 세척술 (BAL)을 통해 획득한 호흡기 검체에서 분리된 균주에 대한 항균제 내성 실태
김종엽 ( Jong Yeop Kim ),김철홍 ( Cheol Hong Kim ),박수희 ( Su Hee Park ),고유상 ( You Sang Ko ),김미정 ( Mi Jeong Kim ),강혜련 ( Hye Ryun Kang ),황용일 ( Yong Il Hwang ),박용범 ( Yong Bum Park ),장승훈 ( Seung Hun Jang ),우흥정 ( 대한결핵 및 호흡기학회 2007 Tuberculosis and Respiratory Diseases Vol.62 No.6
연구배경: 원내 폐렴의 적절한 항균제 치료를 위해서는 원발 병소에서의 원인균 규명과 항균제에 대한 내성 유무 확인이 필수적이다. 본 연구는 원내 폐렴이 의심되는 경우 기관지내시경을 통한 정량적 기관지폐포 세척술(bronchoalveolar lavage, BAL) 배양검사를 시행하여 빈번하게 분리되는 균주와 이들의 항균제 내성 현황을 알아보고자 하였다. 방법: 2004년 1월부터 2006년 6월까지 한림의대 한강성심병원 화상 중환자실과 비화상 중환자실에서 폐 침윤의 원인규명 위해 BAL 검사를 시행하였다. 104 CFU/mL 이상의 균주가 분리되면 양성으로 판정하였다. 결과: BAL 검사 결과 화상중환자실 27예(77.1%), 비화상중환자실 22예(59.4%)에서 배양 양성이었다. 분리되는 주요 균주는 S. aureus, Acinetobacter species 및 P. aeruginosa였다. 화상중환자실에서 분리된 S. aureus의 경우 전부 MRSA(100%)였으며, 비화상중환자실에서는 71.4%가 MRSA로 보고되었다. P. aeruginosa의 경우 화상중환자실 및 비화상중환자실에서 amikacin 54.6% vs. 50.0%, ciprofloaxacin 100% vs. 50%, cefepime 90.9% vs. 50%, imipenem 72.7% vs. 50%, ceftazidime 45.5% vs. 25% 및 piperacillin/tazobactam 90.9% vs. 50%의 내성률을, Acinetobacter species의 경우는 amikacin 90.9% vs. 100%, ciprofloxacin 100% vs. 87.5%, cefepime 90.9% vs. 100%, imipenem 100% vs. 62.5%, ceftazidime 90.9% vs. 100% 및 piperacillin/tazobactam 81.8% vs. 62.5%의 내성률을 보여주었다. 결론: 화상중환자실과 비화상중환자실에서 원내 폐렴이 의심되는 환자의 원인균 분포와 약제 내성 현황을 알 수 있었으며 향후 항균제 치료 전략에 도움을 줄 것으로 사료된다. Background: Nosocomial pneumonia in an intensive care unit (ICU) is associated with a high mortality rate. Diagnosing a respiratory tract infection in critically ill patients is still difficult but detailed information for the pathogens is needed to establish an adequate antimicrobial treatment. This study examined the causative organisms and their antimicrobial resistance using bronchoalveolar lavage (BAL) from patients suspected of having pneumonia in the ICU. Methods: From January 2004 to June 2006, ICU patients with diffuse lung infiltration were prospectively enrolled. The BAL was used to diagnose the respiratory infection, with 104 ≥ organisms considered a positive result. The most common organisms and their antimicrobial resistances were analyzed from the quantitative BAL cultures in the burn ICU and non-burn ICU. Results: A total 72 patients were included, 35 (M 29, F 6) in the burn ICU and 37 (M 26, F 11) in the non-burn ICU. 27 patients (77.1%) in the burn ICU and 22 patients (59.5%) in the non-burn ICU met the criteria for a positive BAL culture. The major pathogens were Staphylococcus aureus, Acinetobacter species and Pseudomonas aeruginosa. All strains (100%) of Staphylococcus aureus isolated from BAL (9 cases) were methicillin-resistant (MRSA) in the burn ICU, but 5 strains (71.4%, 7 cases) were MRSA in the non-burn ICU. Regarding Pseudomonas aeruginosa, the rate of resistance to amikacin, ciprofloxacin, cefepime, imipenem, ceftazidime, piperacillin/tazobactam in the burn and non-burn ICU ranged from 45.5% to 90% and 25% to 50%, respectively. In addition, the rate of resistance of Acinetobacter species to the above drugs in the burn and non-burn ICU ranged from 81.8% to 100% and 62.5% to 100%, respectively. Conclusions: These results are expected to provide useful guidelines for choosing the effective empirical antimicrobial therapy in patients with lung infiltrations in the burn and non-burn ICU. (Tuberc Respir Dis 2007; 62: 506-515)
임상연구 : 통원수술 환자에서 Propofol과 Remifentanil 목표농도조절주입과 소량의 Rocuronium을 병용한 마취유도 시 기관내삽관의 조건과 혈역학 변화
김종엽 ( Jong Yeop Kim ),김재형 ( Jae Hyung Kim ),박성용 ( Sung Yong Park ),이현호 ( Hyun Ho Lee ) 대한마취과학회 2006 Korean Journal of Anesthesiology Vol.51 No.5
Background: This study evaluated the tracheal intubating conditions and hemodynamic changes in tracheal intubation according to the different effect-site concentrations of remifentanil combined with a target controlled infusion (TCI) of propofol using low dose rocuronium. Methods: Forty-five patients presenting for ambulatory surgery were randomly assigned to one of three groups according to the target effect-site concentration of remifentanil: 2.5 ng/ml (group R2.5), 3.0 ng/ml (group R3.0), 3.5 ng/ml (group R3.5). After midazolam administration, anesthesia was induced using a target effect-site controlled infusion of propofol 4.0μg/ml, which was then reduced to 2.5μg/ml. At the same time, a TCI of remifentanil was started. A neuromuscular blockade was produced by rocuronium 0.4 mg/kg. The trachea was intubated 4 min after induction. The tracheal intubation conditions were assessed using a standard scoring system. The noninvasive arterial blood pressure, heart rate (HR), and bispectral index were recorded at 1 min intervals from the start of induction to 5 min after intubation. Results: Intubation was successful in all patients except for one in the R2.5 group. The number of excellent intubating conditions was significantly higher in the R3.5 group (12/15) than in the R2.5 group (6/15) (P < 0.05). The mean arterial pressure (MAP) in the R2.5 and R3.0 groups increased significantly at 1 min after intubation (P < 0.05), but the MAP in the R3.5 group increased slightly at 1 min after intubation. Conclusions: The effect-site concentration of remifentanil 3.5 ng/ml combined with a TCI of propofol using rocuronium 0.4 mg/kg provides the most adequate intubating conditions and hemodynamic stability. (Korean J Anesthesiol 2006; 51: 535~40)